Immune Design's Series C Round

Immune Design raised a round of funding on October 30, 2013.

Immune Design is a clinical-stage biotechnology company developing two synergistic platforms of next-generation vaccines designed to treat cancer, infectious diseases, allergy, and autoimmune disorder…

Articles about Immune Design's Series C Round: